Hints and tips:
...This week there was some good news for gene therapies when Bluebird Bio’s treatment for beta-thalassemia received FDA approval....
...Of course, if you want to learn more about someone, why not look at the bio on their website? Giancarlo’s bio on the Bitfinex site is pretty detailed....
...He said the primary concern remained access to credit, although this sector was also transforming with the arrival of ag-fintechs who finance farmers using digital platforms and apps....
...He said it had pooled its internal information into three large data “lakes”, overcoming the barriers that often make it hard to combine different data sets, and employs about 800 data scientists and bio-statisticians...
...Aside from working for Huang, Lei only lists a series of internships at Google, Yahoo and IBM in his executive bio. (Google told the FT it has no record of his time at the company.)...
...And it's a bit of his bio too. I mean, if you've followed Biden's career, what you know is he also was sort of looked down upon by the East Coast elites....
...Unlike AveXis, which first launched Zolgensma in the US, Bluebird Bio has chosen to debut its product in Europe, where there is a concentration of Beta thalassaemia patients....
...Jeremy Levin, chair of the industry group Bio and chief executive of biotech Ovid Therapeutics, said investments had soared in rare diseases and oncology for two reasons: clinical trials were smaller and...
...Bluebird Bio and cross town rival Novartis are among the companies who are experimenting with so-called outcome-based pricing, in a bid to reduce the upfront cost of pricey drugs as a way of hedging against...
...Sartorius Stedim Biotech Sector: Pharmaceuticals / HQ: Aubagne, France The French company was born out of a merger of Stedim and Sartorius AG’s biotech division in 2007....
...Indigo Ag, the Boston-based start-up that connects sellers and buyers of crops through a mobile app, raised $250m, bringing its estimated value to more than £3bn....
...And last month, Syngenta Ventures led a $12m series B funding round in Asilomar Bio, which uses chemistry to improve crop yields....
...According to specialist publication Gasworld, already tight supplies were exacerbated a few weeks ago when other plants involved in bio-ethanol and chemical production were shut down, either because of technical...
...Bluebird bio added 15 per cent in early trading following a promising update on its gene therapy for sickle cell disease....
...Glenn Cohen, a bio-ethicist at Harvard who was commissioned by Otsuka to examine potential ethical issues surrounding the technology, says he knows of no plans to use it in coercive settings — for example...
...Shares in the bio-tech group opened at SFr10 on Friday and ended at SFr13.65 in Europe, valuing Idorsia at about SFr1.5bn — which was at the high end of analyst forecasts....
...Novartis said it had exercised its right to acquire the bio-pharmaceutical firm based in Oklahoma City after receiving the results of a phase II trial evaluating the use of a specific antibody to reduce...
...Courtesy of Nomura’s Sonal Varma: Here’s their bios, from the same place: That’s obviously not all of the names being put forward but it’s a good start....
...UBS is being advised by MPM Capital, a Boston-based bio-venture fund manager that specialises in identifying breakthrough therapies and creating companies to advance them....
...The second proposal was that Array BioPharma would acquire both products. However, there would need to be a significant European partner to ensure the drugs’ position in the EU market....
...Its reference to “public scrutiny” highlights specific concerns about Monsanto’s controversial position as a leader in bio-engineered foods — a fact that could pose an obstacle to any deal by it as it would...
...Bio-based feedstocks have great potential, says Professor James Clark, head of the Green Chemistry Centre of Excellence at the University of York, in England....
...Roche said there were “currently no approved bio-similars of Herceptin in India”, but Ms Menon-Sen said at least two Indian companies were developing equivalents....
...PRUK, with annual sales of more than £110m, operates Bio Products Laboratory, established in 1950 and employing 200 people in Elstree, and a further 1,000 staff at DCI Biologicals of the US....
...Companies such as Bio Bulgaria, owned by Bulgarian tennis legend Magdalena Maleeva, are pioneering the export of high-quality organic produce....
International Edition